Arthritis Research & Therapy

official impact factor 4.36

Open Access Email this article to a friend

Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment

Heiner Appel*, Louise Janssen, Joachim Listing, René Heydrich, Martin Rudwaleit and Joachim Sieper

Arthritis Research & Therapy 2008, 10:R125 doi:10.1186/ar2537

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.